Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN14688109
ISRCTN14688109
Recruiting
Not Applicable

Investigation of the potential beneficial effects of cannabidiol in the management of oral-lingual-buccal dyskinesias using animal studies and a clinical trial

Stellenbosch University0 sites60 target enrollmentStarted: May 7, 2015Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTardive dyskinesiaNervous System DiseasesDrug-induced dystonia

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
60
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1\. Adults 18 years and older
  • •2\. Currently meets the ICD\-10 diagnosis of a psychotic disorder, verified with the Mini International Neuropsychiatric Interview (MINI\-PLUS) questionnaire.
  • •3\. Currently meets the clinical diagnosis of tardive dyskinesia confirmed with the Abnormal Involuntary Movement Scale (AIMS)
  • •4\. Patients should currently be receiving treatment for a psychotic disorder and should be on either the atypical or conventional antipsychotics
  • •5\. Patient gives informed consent

Exclusion Criteria

  • •1\. ICD\-10 diagnosis of an organic mental illness, substance misuse disorder or a seizure disorder
  • •2\. Serious or chronic physical illness
  • •3\. Known severe drug allergies or hypersensitivity to CBD

Investigators

Similar Trials

Completed
Not Applicable
Effect of anterior chamber paracentesis to control the pressure of the eye after cataract surgery
IRCT20091030002647N2Kerman University of Medical Sciences68
Completed
Not Applicable
Study to valuate the potential benefits of a patient information leaflet about driving regulation and mental illness
ISRCTN53469570Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Recruiting
Not Applicable
Prospective clinical investigation of the effects of bariatric surgery on nocturnal hypoxaemic burden in patients with severe obesityE66.02G47.9Sleep disorder, unspecified
DRKS00026004Klinikum Saarbrücken100
Active, not recruiting
Not Applicable
A prospective study to assess the impact and benefits of an artificial intelligence system in double reading for breast cancer screening
ISRCTN95571932Kheiron Medical Technologies (United Kingdom)6,876
Active, not recruiting
Phase 1
BALLAD- a trial to evaluate the potential benefit of adjuvant chemotherapyfor small bowel adenocarcinoma
EUCTR2013-003047-29-DKGreater Glasgow and Clyde Health Board580